Propranolol

Propranolol

Propranolol is a prescription drug originally developed in the 1960s for high blood pressure and angina. It belongs to a class called beta-blockers, which work by sitting in the receptors that adrenaline normally binds to. Adrenaline is what your body floods into your bloodstream during stress, fear, or excitement, and it's what causes your heart to race, your hands to shake, your voice to tremble, your face to flush, and your stomach to churn. Propranolol blocks those receptors, so when the adrenaline shows up, it has nowhere to act. The signal gets sent, but the body doesn't respond to it.
Most people today take it for that exact reason: it strips the physical symptoms out of acute stress. You take 10-40 mg about an hour before something that would normally make your body go into fight-or-flight mode, and most of that just doesn't happen. The mental sense of nerves can still be there, but the body stays quiet enough that the physical reaction stops feeding the anxiety back into your head. This is why it's been the open secret of public speakers, musicians, actors, surgeons, snipers, and competitive shooters for decades.
It's also a first-line treatment for preventing migraines and for reducing essential tremor (the involuntary shaking of the hands that gets worse with age), and it has a more experimental use for softening the emotional charge of traumatic memories. It's not addictive, it's cheap, it's been around long enough that the safety profile is well understood, and for performance anxiety specifically there's almost nothing else that works this cleanly. The two real catches are asthma (it can trigger airway constriction) and very low resting blood pressure or heart rate (it lowers both).

Deep-dive

Propranolol is a non-selective beta-adrenergic receptor antagonist. It blocks both β1 receptors (mostly in the heart, kidneys, and fat tissue) and β2 receptors (in lungs, vascular smooth muscle, liver). Adrenaline and noradrenaline normally bind these receptors during the fight-or-flight response, which is what produces the racing heart, the tremor, the sweating, the gut churn, the pounding pulse in your ears. Propranolol sits in those receptor sites and blocks the catecholamines from latching on, so the physical cascade just doesn't fire. It crosses the blood-brain barrier, unlike some other beta-blockers, which is part of why it works on tremor and seems to affect emotional memory at the brain level as well as the body.
Orally absorbed propranolol undergoes heavy first-pass metabolism in the liver, so systemic bioavailability is only around 25%, with wide person-to-person variation. Peak plasma concentration hits at 1-2 hours, elimination half-life is roughly 3-6 hours for the immediate-release form, and the long-acting (LA) version stretches dosing to once daily. This matters practically: you take it about 60-90 minutes before the event, and the useful window lasts roughly 3-4 hours.
Performance anxiety. This is the most evidence-backed and most widely used off-label application. A double-blind crossover trial in musicians found propranolol eliminated the physical symptoms of stage fright and that the quality of the musical performance, judged by experienced critics, significantly improved, without any sedation. A trial in adolescents gave 40 mg an hour before the SAT to students with severe test anxiety and found their scores rose 130 points compared to their pre-medication attempt. A study in ophthalmology residents found 40 mg given an hour before surgery significantly reduced hand tremor and observer-rated anxiety. A 2022 review covering several decades of stage fright literature confirms that beta-blockers, propranolol in particular, are the most reliable pharmacological option for performance anxiety. The mechanism here is partly peripheral, no racing heart and no tremor means less feedback into the brain telling you that you're terrified, and partly central, since propranolol crosses the blood-brain barrier and blunts the noradrenaline-driven anxiety circuit directly.
Importantly, propranolol doesn't make you feel sedated or impaired in the way a benzo does. People consistently report feeling like themselves, just without the physical fear response. This is the reason it's been used informally for high-skill performance situations where any cognitive dulling would be a disaster.
Migraine prophylaxis. Propranolol has been first-line for preventing migraine attacks since the 1970s. A 2019 European Headache Federation meta-analysis confirmed it as a first-line agent, with a meaningful reduction in monthly migraine days compared to placebo. Typical effective dose is 80-160 mg/day, sometimes pushed to 160-240 mg/day for full effect. Onset of prophylactic benefit takes 4-8 weeks of consistent dosing, so it's not a rescue medication for an active migraine, it's a daily preventer. Mechanism is thought to involve a mix of cerebrovascular vasoconstriction, 5-HT receptor modulation, and dampening of the noradrenergic input into the trigeminal system.
Essential tremor. The other classic on-label use. Double-blind trials going back to the 1970s show clear improvement in tremor amplitude, particularly in the upper limbs. Effective doses are usually higher than for anxiety, often 240-320 mg/day. The benefit is measurable on grooved pegboard tests and on observer-rated handwriting quality. Not everyone responds, and the effect can fade somewhat over months, but for people whose tremor disrupts work or daily function this is one of the most effective options.
Traumatic memory and PTSD. This is the more experimental angle, and it's interesting because it suggests propranolol might be more than just a beta-blocker, it might be able to soften the emotional charge attached to specific memories. The theory is that every time you recall a memory, it briefly becomes 'labile' again before it's restored, and during that window the noradrenaline-driven emotional component can be blocked. A 2018 randomised controlled trial by Brunet et al. gave 60 long-standing PTSD patients propranolol or placebo 90 minutes before a brief weekly memory reactivation session for 6 weeks, and the propranolol group showed significant symptom reduction. A 2020 pilot study in people with severe fear of public speaking using a similar reconsolidation protocol found lasting reductions in anxiety at 1 and 3 month follow-up. The evidence isn't unanimous, a 2022 meta-analysis found mixed results across PTSD trials with significant heterogeneity in protocols, so this is best thought of as promising and protocol-dependent rather than settled. It's not a replacement for trauma-focused therapy, but it appears to potentiate it when timed correctly.
Pharmacokinetics, sex differences, and dosing. Men clear propranolol significantly faster than women. A pharmacokinetic study found oral clearance was 63% higher in men than in women after the same 80 mg dose, mainly driven by faster side-chain oxidation in men. Practically, the same dose produces a higher and longer-lasting plasma concentration in women, which means women often do well on the lower end of the dose range (10-20 mg for performance anxiety) where men may need 20-40 mg for the same effect. Oral contraceptives further slow clearance via effects on alpha-1 acid glycoprotein binding. Older adults clear propranolol 2-3 times more slowly than younger adults regardless of sex, so doses get pulled back further in people over 65.
Women. Beyond pharmacokinetics, the on-label and off-label uses translate similarly between sexes. Migraine is roughly three times more common in women than men, particularly in the menstruating years, and propranolol prophylaxis is well established in this population. There's no specific dose adjustment for performance anxiety in women beyond accounting for slower clearance, so 10-20 mg is often a sensible starting point. The one real caveat is pregnancy. Propranolol crosses the placenta and is classified as Pregnancy Category C in older labels, associated in some studies with low birth weight, small placentas, and neonatal effects like hypoglycaemia and bradycardia if used near term. Most clinicians try to avoid it in pregnancy unless the indication (severe hypertension, frequent disabling migraine) outweighs the risk. Breastfeeding produces only small amounts in breast milk and is generally considered compatible, but worth confirming with a prescribing clinician.
Older adults. Slower clearance, smaller starting doses, more sensitivity to the bradycardia and hypotension. Also more likely to have asthma, COPD, peripheral vascular disease, or sick sinus syndrome, all of which are contraindications or cautions. Useful but needs careful prescribing.

Dosage:

  • Performance anxiety, acute single dose: 10-40 mg taken 60-90 minutes before the event. Most people land at 20 mg. Women, smaller-framed people, and anyone over 65 should start at 10 mg the first time, since clearance is slower and the same dose lasts longer. Larger men or anyone who's tried 20 mg and felt no difference can go to 40 mg
  • Always test first. Never take propranolol for the first time on the day of an important event. Try it once on a normal day to see how your body responds. A small minority of people get noticeable fatigue, dizziness, or a flat affect, and you don't want to learn that 30 minutes before walking on stage
  • Migraine prevention: 80-160 mg/day, usually split into two doses of immediate-release or as a single dose of long-acting (LA). Doses up to 240 mg/day are used if the lower range doesn't reduce attack frequency. Takes 4-8 weeks of consistent daily dosing to see full effect, don't write it off in the first month
  • Essential tremor: 120-320 mg/day, typically split. Higher doses than for anxiety. Effect builds over weeks
  • Timing for performance use: 60-90 minutes before the event is the sweet spot for immediate-release. Eating doesn't matter much, food slightly reduces peak concentration but the effect is small
  • Don't combine with alcohol. Both lower blood pressure, and the combination can produce more dizziness, slower reflexes, and a flatter mood than either alone
  • Don't stop chronic use abruptly. If you've been taking propranolol daily for migraine, tremor, blood pressure, or anxiety for more than a couple of weeks, taper over 1-2 weeks rather than stopping cold. Beta receptors upregulate during chronic blockade, and sudden withdrawal can produce rebound tachycardia, hypertension, and in people with underlying heart disease, angina or arrhythmia. Single doses for performance anxiety don't need tapering
  • Forms: Immediate-release 10, 20, 40, 60, and 80 mg tablets. Long-acting (Inderal LA, others) 60, 80, 120, 160 mg capsules, used for daily prophylaxis. For acute performance use, only the immediate-release form makes sense

Here's what you can expect:

Within 45-60 minutes of a 10-20 mg dose, the physical signs of acute stress go quiet. Your heart doesn't race, your hands don't shake, your voice doesn't tremor, your face doesn't flush, and the pounding in your chest doesn't ramp up the way it normally would when something high-stakes starts. Most people describe it as feeling like themselves but with the volume turned down on the body's fear response. You can still feel mentally nervous, the thought 'this is important' doesn't go anywhere, but the body stops feeding that feeling back to itself.
What propranolol does not do is sedate you, blur your thinking, or change your mood. There's no euphoria, no dulling, no spaciness. This is the main reason it's preferred over benzos for high-skill performance situations.
For migraine and tremor used daily, the effect is gradual and most noticeable in retrospect. Attacks become less frequent or less severe over weeks, tremor amplitude drops over days to weeks. You're unlikely to feel anything subjective from the dose itself once you're adjusted, beyond perhaps a slightly lower resting heart rate.
If you take too high a dose, especially the first time, expect noticeable fatigue, light-headedness on standing up quickly, cold hands and feet, and occasionally a slightly low mood. These resolve within a few hours and are a sign to drop the dose next time.

Side effects & risks:

  • Bradycardia and hypotension. Propranolol lowers heart rate and blood pressure. In most healthy people the drop is modest and unproblematic, but if your resting heart rate is already below 60 or your blood pressure runs low (systolic below 100), even a small dose can produce light-headedness, fatigue, or fainting on standing. Endurance athletes with naturally low resting heart rates are particularly affected
  • Asthma and reactive airway disease. This is the most important contraindication. Propranolol blocks β2 receptors in the lungs, which can trigger bronchospasm in people with asthma or COPD. For someone with active asthma this can be severe. If you have any history of wheeze, exercise-induced bronchospasm, or chronic bronchitis, raise this with your prescriber. Selective β1-blockers like bisoprolol are sometimes used as alternatives, though even these aren't fully safe in significant asthma
  • Cold extremities and Raynaud's. β2 blockade reduces peripheral vasodilation, so hands and feet can feel cold. People with Raynaud's phenomenon often find symptoms worsen on propranolol
  • Fatigue, vivid dreams, and low mood. Because propranolol crosses the blood-brain barrier, it can produce a flat or slightly depressed mood, vivid or disturbed dreams, and noticeable fatigue, particularly at higher daily doses. If you have a history of depression, this is worth flagging before starting chronic use
  • Exercise tolerance drops. Maximal heart rate is blunted, so high-intensity training will feel harder and peak output is lower. This matters if you train seriously. Endurance and strength sports can still be performed but expect reduced ceiling on hard sessions
  • Hypoglycaemia masking in diabetes. Propranolol blunts the adrenaline response that normally signals low blood sugar (racing heart, sweating). For people with insulin-dependent diabetes, this means hypoglycaemia can become symptomatically silent and dangerous. Not an absolute contraindication but needs careful management
  • Drug interactions. Major ones include other antihypertensives (additive BP drop), verapamil and diltiazem (severe bradycardia risk), MAOIs, certain antiarrhythmics, and rizatriptan for migraine (propranolol roughly doubles rizatriptan levels). Always disclose the full medication list to a prescriber
  • Pregnancy. Crosses the placenta. Associated with low birth weight, neonatal bradycardia and hypoglycaemia, particularly with chronic use near term. Generally avoided unless the maternal indication is strong
  • Rebound on abrupt discontinuation. After chronic use, stopping suddenly can produce rebound tachycardia, hypertension, and in people with underlying coronary disease, angina or arrhythmia. Always taper
  • Sexual function. Some men report reduced libido or erectile difficulties on chronic propranolol. Usually mild and reversible on stopping. Less data in women, but reduced arousal is occasionally reported
  • Heart block, sick sinus syndrome, decompensated heart failure. All hard contraindications. The bradycardic effect can be dangerous in conduction disorders

🩸

Blood markers

Resting heart rate and blood pressure, baseline before any use. Sit quietly for 5 minutes and measure both. If your resting HR is below 55 or your systolic BP is below 100, talk to a prescriber before using propranolol, even for one-off performance anxiety. For chronic daily use, recheck both after 2-4 weeks at the target dose to confirm you're not over-shot.
ECG, baseline if you have any history of palpitations, fainting, heart disease in the family, or are over 60 considering chronic use. Propranolol is contraindicated in second or third-degree heart block and in sick sinus syndrome, and an ECG is the only way to catch these.
Fasting glucose and HbA1c, baseline if you have diabetes or are at risk. Propranolol masks the adrenaline-driven warning signs of hypoglycaemia, so knowing your baseline glycaemic control matters.
Spirometry or peak flow, if you have any history of asthma, exercise-induced wheeze, or COPD. If lung function is impaired, propranolol is the wrong drug.
Liver enzymes (ALT, AST), baseline for chronic use. Propranolol is hepatically metabolised and significant liver dysfunction prolongs its half-life substantially.
For someone using 10-40 mg occasionally before a presentation or performance, no specific bloodwork is needed beyond a resting HR/BP check and a clear answer on whether they have asthma. The people who actually need full baseline testing are those starting chronic daily use for migraine, tremor, or hypertension, anyone with cardiac or pulmonary history, diabetics, and older adults.
Available by prescription in most countries.